-
Earnings Scheduled For July 18, 2014
Friday, July 18, 2014 - 4:21am | 349Read More...General Electric Company (NYSE: GE) is projected to report its Q2 earnings at $0.39 per share on revenue of $36.30 billion. Autoliv (NYSE: ALV) is expected to report its Q2 earnings at $1.55 per share on revenue of $2.34 billion. Honeywell International (NYSE: HON) is projected to report its Q2...
-
Top 4 NASDAQ Stocks In The Home Health Care Industry With The Highest Gross Margin
Friday, May 16, 2014 - 3:47am | 118Read More...Below are the top home health care stocks on the NASDAQ in terms of gross margin. The trailing-twelve-month gross margin at Almost Family (NASDAQ: AFAM) is 46.50%. Almost Family's PEG ratio is 2.08. The trailing-twelve-month gross margin at Gentiva Health Services (NASDAQ: GTIV) is 45.40%....
-
Earnings Scheduled For April 25, 2014
Friday, April 25, 2014 - 4:45am | 569Read More...Ford Motor Co (NYSE: F) is expected to report its Q1 earnings at $0.31 per share on revenue of $34.06 billion. Autoliv (NYSE: ALV) is projected to report its Q1 earnings at $1.43 per share on revenue of $2.30 billion. Alaska Air Group (NYSE: ALK) is estimated to report its Q1 earnings at $1.24...
-
ARCA biopharma Announces Screening of First Patient in Phase 2B/3 Clinical Trial Evaluating Gencaro in Atrial Fibrillation
Thursday, April 17, 2014 - 7:31am | 1051Read More...ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically targeted therapies for cardiovascular diseases, today announced that the first patient has been genetically screened in GENETIC-AF, its Phase 2B/3 adaptive design clinical trial. The GENETIC-AF trial will...
-
Top 4 NASDAQ Stocks In The Home Health Care Industry With The Lowest PEG Ratio
Wednesday, March 19, 2014 - 3:26am | 106Read More...Below are the top home health care stocks on the NASDAQ in terms of PEG ratio. Gentiva Health Services (NASDAQ: GTIV) has a PEG ratio of 1.20. Gentiva Health's trailing-twelve-month revenue is $1.73 billion. Addus HomeCare (NASDAQ: ADUS) has a PEG ratio 1.37. Addus HomeCare's trailing-twelve-...
-
Earnings Scheduled For March 5, 2014
Wednesday, March 5, 2014 - 4:41am | 781Read More...Brown-Forman (NYSE: BF-B) is projected to report its Q3 earnings at $0.76 per share on revenue of $1.07 billion. PetSmart (NASDAQ: PETM) is expected to report its Q4 earnings at $1.21 per share on revenue of $1.83 billion. Canadian Solar (NASDAQ: CSIQ) is estimated to post a Q4 loss at $0.20 per...
-
Earnings Scheduled For February 7, 2014
Friday, February 7, 2014 - 4:56am | 443Read More...Cigna (NYSE: CI) is expected to report its Q4 earnings at $1.49 per share on revenue of $7.35 billion. American Axle & Manufacturing Holdings (NYSE: AXL) is estimated to report its Q4 earnings at $0.48 per share on revenue of $864.10 million. Beacon Roofing Supply (NASDAQ: BECN) is projected...
-
Stocks To Watch For February 7, 2014
Friday, February 7, 2014 - 4:18am | 171Read More...Some of the stocks that may grab investor focus today are: Wall Street expects Cigna (NYSE: CI) to report its Q4 earnings at $1.49 per share on revenue of $7.35 billion. Cigna shares gained 3.78% to $88.60 in after-hours trading. LinkedIn (NYSE: LNKD) reported upbeat fourth-quarter results....
-
Illumina Signs Master Supply Agreement with LabCorp
Tuesday, January 21, 2014 - 6:32am | 84Read More...Illumina (NASDAQ: ILMN) today announced it has entered into a multi-year supply agreement with Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH). The agreement gives LabCorp expanded rights to use Illumina next-generation sequencing (NGS) and microarray...
-
ARCA Biopharma Announces FDA Acceptance of Gencaro Companion Diagnostic Test IDE
Wednesday, January 8, 2014 - 8:31am | 147Read More...ARCA biopharma, Inc. (Nasdaq: ABIO), a biopharmaceutical company developing genetically-targeted therapies for cardiovascular diseases, today announced that Laboratory Corporation of America (LabCorp®) (NYSE: LH) has informed ARCA that the U.S. Food and Drug Administration (FDA...
-
Benzinga's Top #PreMarket Losers
Wednesday, December 11, 2013 - 8:34am | 122Read More...Avanir Pharmaceuticals (NASDAQ: AVNR) shares fell 16.32% to $3.59 in the pre-market trading after the company reported that phase II PRIME study of investigation drug AVP-923 did not meet primary efficacy endpoint. The company also reported a wider Q4 loss. Laboratory Corp. of America Holdings (...
-
Stocks To Watch For December 11, 2013
Wednesday, December 11, 2013 - 4:18am | 185Read More...Some of the stocks that may grab investor focus today are: Wall Street expects Joy Global (NYSE: JOY) to report its Q4 earnings at $1.12 per share on revenue of $1.12 billion. Joy Global shares rose 0.32% to $56.42 in after-hours trading. MasterCard (NYSE: MA) announced a 10-for-1 stock split....
-
Earnings Scheduled For October 18, 2013
Friday, October 18, 2013 - 3:39am | 399Read More...Morgan Stanley (NYSE: MS) is estimated to report its Q3 earnings at $0.40 per share on revenue of $7.70 billion. Baker Hughes (NYSE: BHI) is expected to report its Q3 earnings at $0.78 per share on revenue of $5.77 billion. General Electric Company (NYSE: GE) is projected to report its Q3...
-
Benzinga's Top Initiations
Friday, September 13, 2013 - 6:58am | 143Read More...Analysts at Cantor Fitzgerald initiated coverage on shares of Laboratory Corporation of America Holdings (NYSE: LH) with a “buy” rating. The target price for Laboratory Corporation is set to $115. Laboratory Corporation's shares closed at $100.05 yesterday. JP Morgan initiated coverage on shares...
-
Benzinga's Top Pre-Market Gainers
Monday, August 12, 2013 - 7:16am | 121Read More...F5 Networks (NASDAQ: FFIV) moved up 2.57% to $92.19 in the pre-market session after analysts at Barclays upgraded the stock from “equal-weight” to “overweight.” Merrimack Pharmaceuticals (NASDAQ: MACK) soared 2.52% to $4.47 in the pre-market trading. Merrimack shares have dropped 42.93% over the...
